Non replicating viral vector - living meta-analysis of clinical studies

table network network 2

demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study

	infections other than COVID-19
Non replicating viral vector
Ad26.RSV.preF (respiratory syncytial virus)	Sadoff
Ad26.ZEBOV ()	Afolabi
Ad26.ZIKV.001 (Ad26-Vectored Anti-Zika Virus Vaccine)	Salisch

6 studies excluded by filtering options 2

4830	NCT04276896, 0	2	30	0	excluded	not a RCT	risk of bias not avaialble
4992	Candidate COVID-19 Vaccine (COV001), 2020	2	1	0	excluded		risk of bias not avaialble
6444	Barrett, 2020	2	0	0	excluded		risk of bias not avaialble
8160	Babamahmoodi, 2021	2	99	0	excluded	not a RCT	risk of bias not avaialble
9070	Tobaiqy M, 2021	2	32	0	excluded	not a RCT	risk of bias not avaialble
9376	Nanthapisal, 2022	2	1	0	excluded		risk of bias not avaialble